| Symbol | CINGW |
|---|---|
| Name | CINGULATE INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1901 W. 47TH PLACE, KANSAS CITY, Kansas, 66205, United States |
| Telephone | +1 913 - 942-2300 |
| Fax | — |
| — | |
| Website | https://www.cingulate.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001862150 |
| Description | Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. Additional info from NASDAQ: |
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
Read moreCingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
Read moreCingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
Read moreDirector Schaffer Shane J. 🟢 acquired 295.0K shares (2 derivative) of Cingulate Inc. (CING) at $4.43 ($1.3M) Transaction Date: Jul 16, 2026 | Filing ID: 033972
Read moreDowney Bryan Wade 🟢 acquired 100.0K shares (2 derivative) of Cingulate Inc. (CING) at $4.43 Transaction Date: Jul 16, 2026 | Filing ID: 033970
Read moreDirector Lawrence Bryan Jay 🟢 acquired 20.0K shares (1 derivative) of Cingulate Inc. (CING) at $4.43 Transaction Date: Jul 16, 2026 | Filing ID: 033968
Read moreBrams Matthew 🟢 acquired 80.0K shares (2 derivative) of Cingulate Inc. (CING) at $4.43 Transaction Date: Jul 16, 2026 | Filing ID: 033967
Read moreDirector Hargroves Thomas Jeffrey 🟢 acquired 20.0K shares (1 derivative) of Cingulate Inc. (CING) at $4.43 Transaction Date: Jul 16, 2026 | Filing ID: 033964
Read more